Search results for "Hepatitis C"


 
Results 41 - 50 of about 57 for "Hepatitis C".

Did you mean "hepatitis"?

Sort by: Relevance | Newest | Oldest

Spotlight on HCV and organ transplants

Over the past month, multiple studies found that kidney and liver transplantation using organs from deceased donors with hepatitis C virus (HCV) infection may be effective in HCV-negative recipients treated with a direct-acting antiviral regimen.
https://gastroenterology.acponline.org/archives/2020/09/25/5.htm
25 Sep 2020

Best practices for HCV care include less invasive testing for many patients, says ACP

The College's new advice on treating hepatitis C virus (HCV) identifies patients who can be safely treated in primary care with laboratory monitoring limited to the beginning and end of treatment and no invasive testing.
https://gastroenterology.acponline.org/archives/2020/10/23/6.htm
23 Oct 2020

Spotlight on The Liver Meeting

Highlights from the American Association for the Study of Liver Diseases' annual meeting, held virtually this past weekend, included insights on COVID-19 and the liver and a conversation with the winners of the Nobel Prize in Physiology or Medicine 2020, who discovered hepatitis C virus.
https://gastroenterology.acponline.org/archives/2020/11/20/5.htm
20 Nov 2020

MKSAP Quiz: Hepatocellular carcinoma surveillance after HCV treatment

This month's quiz asks readers to determine the most appropriate biannual surveillance modality for a 62-year-old patient with compensated cirrhosis who was treated for hepatitis C virus (HCV) infection six months ago.
https://gastroenterology.acponline.org/archives/2021/10/22/4.htm
22 Oct 2021

Spotlight on alcoholic hepatitis during the pandemic

Recent studies found increases in patients registering for liver transplants and receiving them, as well as more hospitalizations for alcoholic hepatitis during the COVID-19 pandemic.
https://gastroenterology.acponline.org/archives/2021/11/19/5.htm
19 Nov 2021

U.S. sees decrease in HCC disease burden

Incidence of hepatocellular carcinoma (HCC) decreased sharply by 2.3% annually after 2011, while incidence-based mortality saw a 3.2% annual decrease after 2013, according to a study based on national data.
https://gastroenterology.acponline.org/archives/2022/02/25/2.htm
25 Feb 2022

Spotlight on improving HCV care

A systematic review and meta-analysis assessed which interventions may improve hepatitis C virus (HCV) testing, linkage to care, and treatment initiation, while a randomized trial found that an accessible care model may be superior to facilitated referral at curing HCV in individuals who inject drugs.
https://gastroenterology.acponline.org/archives/2022/03/25/5.htm
25 Mar 2022

Patient navigation associated with increased care, treatment in hepatitis C

A pre-post study in a safety-net health system found higher odds of linkage to care and direct-acting antiviral treatment in older adults who received patient navigation rather than usual care.
https://gastroenterology.acponline.org/archives/2022/05/27/3.htm
27 May 2022

HCV medications decreased liver disease among those using injection drugs

A Baltimore-based study found that half of participants with chronic hepatitis C virus (HCV) and a history of injection drug use at baseline were free of the virus by 2019, with associated reductions in their risk of cirrhosis and mortality.
https://gastroenterology.acponline.org/archives/2022/07/22/2.htm
22 Jul 2022

Aspirin use is associated with reduced risk for hepatocellular carcinoma

The findings of a recent meta-analysis provide support for an association between aspirin use and reduced risk for hepatocellular carcinoma but do not warrant use of aspirin as prophylaxis, and more research is needed, an ACP Journal Club commentary said.
https://gastroenterology.acponline.org/archives/2022/07/22/8.htm
22 Jul 2022

Result Page: Prev   1   2   3   4   5   6   Next